A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction
Conclusions:
D-FOX administered every 2 weeks is a well-tolerated and active regimen in untreated AGC patients.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Study | Taxotere | Toxicology